AT550656T
Method and composition for measuring biological active natriuretic peptide and enhancing the possibility of treatment
Abstract
This record has no abstract on file.
Term
Term ended
Expired 19 August 2024, 2.1 years ago.
- Priority
- Filed
- Granted
- Expired
- Today
146 members in 13 offices
Priority claims3
| Document | Office | Kind | Date |
|---|---|---|---|
| 64587403 | United States of America | A | |
| 54208604 | United States of America | P | |
| 2004026984 | United States of America | W |
Members146
| Document | Office | Kind | |
|---|---|---|---|
| CA2412648A1 | Canada | A1 | |
| WO02083913A1 | World Intellectual Property Organization (WIPO) | A1 | |
| CA2414073A1 | Canada | A1 | |
| WO02089657A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU2002305394A1 | Australia | A1 | |
| US2003022235A1 | United States of America | A1 | |
| CA2457775A1 | Canada | A1 | |
| WO02089657A3 | World Intellectual Property Organization (WIPO) | A3 | |
| WO03016910A1 | World Intellectual Property Organization (WIPO) | A1 | |
| EP1311701A1 | European Patent Office (EPO) | A1 | |
| US2003109420A1 | United States of America | A1 | |
| US2003119064A1 | United States of America | A1 | |
| EP1322957A2 | European Patent Office (EPO) | A2 | |
| US2003199000A1 | United States of America | A1 | |
| US2003219734A1 | United States of America | A1 | |
| EP1419388A1 | European Patent Office (EPO) | A1 | |
| US2004121343A1 | United States of America | A1 | |
| US2004121350A1 | United States of America | A1 | |
| US2004126767A1 | United States of America | A1 | |
| JP2004519688A | Japan | A | |
| JP2004520598A | Japan | A | |
| CA2511482A1 | Canada | A1 | |
| CA2511501A1 | Canada | A1 | |
| CA2692217A1 | Canada | A1 | |
| WO2004058055A2 | World Intellectual Property Organization (WIPO) | A2 | |
| WO2004059293A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU2003300407A1 | Australia | A1 | |
| AU2003300407A8 | Australia | A8 | |
| AU2003302340A1 | Australia | A1 | |
| US2004171064A1 | United States of America | A1 | |
| US2004176914A1 | United States of America | A1 | |
| US2004203083A1 | United States of America | A1 | |
| US2004209307A1 | United States of America | A1 | |
| AU2004232990A1 | Australia | A1 | |
| CA2522670A1 | Canada | A1 | |
| CA2522709A1 | Canada | A1 | |
| US2004219509A1 | United States of America | A1 | |
| WO2004094459A2 | World Intellectual Property Organization (WIPO) | A2 | |
| WO2004094460A2 | World Intellectual Property Organization (WIPO) | A2 | |
| WO2004097368A2 | World Intellectual Property Organization (WIPO) | A2 | |
| US2004253637A1 | United States of America | A1 | |
| WO2004094459A3 | World Intellectual Property Organization (WIPO) | A3 | |
| WO2004094460A3 | World Intellectual Property Organization (WIPO) | A3 | |
| JP2005049351A | Japan | A | |
| CA2535971A1 | Canada | A1 | |
| WO2005019819A1 | World Intellectual Property Organization (WIPO) | A1 | |
| US2005064511A1 | United States of America | A1 | |
| WO2004059293A3 | World Intellectual Property Organization (WIPO) | A3 | |
| WO2004058055A3 | World Intellectual Property Organization (WIPO) | A3 | |
| JP2005121664A | Japan | A | |
| WO2004097368A3 | World Intellectual Property Organization (WIPO) | A3 | |
| US2005148024A1 | United States of America | A1 | |
| JP2005522669A | Japan | A | |
| WO2005071421A1 | World Intellectual Property Organization (WIPO) | A1 | |
| EP1587955A2 | European Patent Office (EPO) | A2 | |
| EP1588159A2 | European Patent Office (EPO) | A2 | |
| WO2005071421A8 | World Intellectual Property Organization (WIPO) | A8 | |
| EP1322957A4 | European Patent Office (EPO) | A4 | |
| EP1311701A4 | European Patent Office (EPO) | A4 | |
| US2005255484A1 | United States of America | A1 | |
| EP1616181A2 | European Patent Office (EPO) | A2 | |
| EP1620726A2 | European Patent Office (EPO) | A2 | |
| EP1419388A4 | European Patent Office (EPO) | A4 | |
| JP3749225B2 | Japan | B2 | |
| CA2579802A1 | Canada | A1 | |
| WO2006029369A2 | World Intellectual Property Organization (WIPO) | A2 | |
| CN1751128A | China | A | |
| US2006063204A1 | United States of America | A1 | |
| EP1656555A1 | European Patent Office (EPO) | A1 | |
| EP1666881A2 | European Patent Office (EPO) | A2 | |
| JP3806694B2 | Japan | B2 | |
| US2006177870A1 | United States of America | A1 | |
| EP1616181A4 | European Patent Office (EPO) | A4 | |
| EP1620726A4 | European Patent Office (EPO) | A4 | |
| JP2006234823A | Japan | A | |
| JP2006523849A | Japan | A | |
| JP2006526140A | Japan | A | |
| JP2006527190A | Japan | A | |
| WO2006029369A3 | World Intellectual Property Organization (WIPO) | A3 | |
| JP2007502991A | Japan | A | |
| AU2002252636B2 | Australia | B2 | |
| EP1587955A4 | European Patent Office (EPO) | A4 | |
| AU2007201180A1 | Australia | A1 | |
| NZ523210A | New Zealand | A | |
| EP1786931A2 | European Patent Office (EPO) | A2 | |
| EP1656555A4 | European Patent Office (EPO) | A4 | |
| EP1666881A3 | European Patent Office (EPO) | A3 | |
| EP1867734A1 | European Patent Office (EPO) | A1 | |
| US2008008696A1 | United States of America | A1 | |
| US2008045444A1 | United States of America | A1 | |
| US7341838B2 | United States of America | B2 | |
| EP1588159A4 | European Patent Office (EPO) | A4 | |
| US7358055B2 | United States of America | B2 | |
| US7361473B2 | United States of America | B2 | |
| JP2008512685A | Japan | A | |
| EP1786931A4 | European Patent Office (EPO) | A4 | |
| NZ532625A | New Zealand | A | |
| US2008160540A1 | United States of America | A1 | |
| JP4119408B2 | Japan | B2 | |
| EP1311701B1 | European Patent Office (EPO) | B1 |
Showing 100 of 146
Numbers
- Application
- 4781634
Titles2
- German
- VERFAHREN UND ZUSAMMENSETZUNGEN ZUR MESSUNG BIOLOGISCH AKTIVER NATRIURETISCHER PEPTIDE UND ZUR VERBESSERUNG IHRES THERAPEUTISCHEN POTENTIALS
- English
- METHOD AND COMPOSITIONS FOR MEASURING BIOLOGICALLY ACTIVE NATRIURETIC PEPTIDES AND FOR IMPROVING THEIR THERAPEUTIC POTENTIALS
Classification
- IPC, 2
- A61K38 00
- G01N33 53